what is a glp-1 agonist Glucagon-like peptide-1 The Landscape Of GLP-1 Receptor

GLP-1s improve survivorship in people with DCIS People with ductal carcinoma in situ (DCIS) are at higher risk of the cancer coming back if they also have obesity and/or diabetes

Reddy S

Setting expectations for each phase prevents discouragement when the pace naturally changes

Guidelines for cardiovascular risk reduction in patients with type 2 diabetes: JACC guideline comparison

Suppressed macrophage infiltration followed by reduced macrophage foam cell formation by active forms of GLP-1 and GIP was demonstrated by Nagashima M, et al

This can be OK for some people who may respond well and not need a more potent drug, or those with less body fat to lose